Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Elinoff

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cardiovascular Research|October 17, 2017
Spironolactone-induced degradation of the TFIIH core complex XPB subunit suppresses NF-κB and AP-1 signallingJason M Elinoff, Li-Yuan Chen, Edward J Dougherty, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 19, 2024
Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2αShuibang Wang, Keytam S Awad, Li-Yuan Chen, et al.
Pulmonary Circulation|July 12, 2021
Pulmonary arterial hypertension patients display normal kinetics of clot formation using thrombelastographyMengyun Lu, Kevin P Blaine, Ann Cullinane, et al.
AIDS (London, England)|July 18, 2022
Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseasesMegan E Hansen, Ralph Mangusan, Kathryn Lurain, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 11, 2023
Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 lossEdward J Dougherty, Li-Yuan Chen, Keytam S Awad, et al.
Circulation|August 25, 2022
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial HypertensionSamuel B Brusca, Jason M Elinoff, Yvette Zou, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 19, 2022
Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat modelMengyun Lu, Li-Yuan Chen, Salina Gairhe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 25, 2014
Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantationJason M Elinoff, Ulas Bagci, Brad Moriyama, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cardiovascular Research|October 17, 2017
Spironolactone-induced degradation of the TFIIH core complex XPB subunit suppresses NF-κB and AP-1 signallingJason M Elinoff, Li-Yuan Chen, Edward J Dougherty, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 19, 2024
Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2αShuibang Wang, Keytam S Awad, Li-Yuan Chen, et al.
Pulmonary Circulation|July 12, 2021
Pulmonary arterial hypertension patients display normal kinetics of clot formation using thrombelastographyMengyun Lu, Kevin P Blaine, Ann Cullinane, et al.
AIDS (London, England)|July 18, 2022
Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseasesMegan E Hansen, Ralph Mangusan, Kathryn Lurain, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 11, 2023
Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 lossEdward J Dougherty, Li-Yuan Chen, Keytam S Awad, et al.
Circulation|August 25, 2022
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial HypertensionSamuel B Brusca, Jason M Elinoff, Yvette Zou, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 19, 2022
Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat modelMengyun Lu, Li-Yuan Chen, Salina Gairhe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 25, 2014
Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantationJason M Elinoff, Ulas Bagci, Brad Moriyama, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
Pageof 3